Real Life Insurance: What the Product Disclosure Statements Actually Say

Written by Christopher Hall, AdvDipFP | Authorised Representative, AFSL 526688 | August 2026

Last verified: August 2026

"Real life insurance" is not one product — it is a family of separately issued policies, and what a policy covers depends on which of them was bought. Real Insurance publishes at least three separate life insurance Product Disclosure Statements in Australia, and the same defined term does not carry the same meaning across them: terminal illness means a life expectancy of 24 months or less in the Real Life Insurance PDS (H9097_12/24, p.43) and 12 months or less in the Real Term Life Cover PDS (H7995_07/23, p.23). Both are issued by Hannover Life Re of Australasia and distributed by Greenstone Financial Services trading as Real Insurance. This article sets out, with document and page references, what each of those PDSs states, and how the same clauses are written in four adviser-distributed products reviewed against the identical fields.

Who issues Real life insurance, and what documents govern it?

The insurer is Hannover Life Re of Australasia Ltd (ABN 37 062 395 484, AFSL 530811). The distributor is Greenstone Financial Services Pty Ltd (ABN 53 128 692 884, AFSL 343079), trading as Real Insurance. The brand on the advertisement is the distributor; the entity that underwrites the policy and pays the claim is the insurer named in the PDS. (Real Life Insurance PDS H9097_12/24, pp.4–5; Real Term Life Cover PDS H7995_07/23, pp.3, 5.)

Three life PDSs were reviewed for this article:

A fourth product, Real Family Life Cover, is referenced in the combined-benefit clauses of the flagship PDS (H9097_12/24, pp.13, 18, 21, 24), but its own PDS was not obtained for this review and no statement is made about it here.

Two Key Fact Sheets accompany the 2023 PDSs — the Term Life Cover KFS is dated November 2022 and the SMSF KFS August 2022, so both pre-date the documents they summarise. The Key Fact Sheet is typically the shorter document a consumer reads first.

Why does the same term mean different things across Real's policies?

Because each is a separate contract with its own defined terms. Across the three PDSs reviewed, six provisions differ:

The row that most often surprises a policyholder at review is the fourth. Under Real Term Life Cover, for the first 12 months after the Acceptance Date only Accidental Death is covered. Where a person dies of an illness in month nine, the Real Term Life Cover policy would not pay a death benefit, because death from any cause other than accident is not covered in that period (H7995_07/23, pp.7, 10, 12). Of the seven documents reviewed for this article, six pay a death benefit from cover commencement; the Real Term Life Cover PDS does not.

The fifth row compounds it. The Real Term Life Cover death benefit ends at the 20th Policy Anniversary or the 85th birthday, whichever is first, after which cover converts to a Final Expenses Benefit of 20% of the original amount for a further ten years with no further premiums payable, and with no terminal illness cover and no Accidental Death Benefit during that period (pp.8, 13–14, 23). Cover cannot be increased and a partner cannot be added at any time after acceptance (p.16).

What does the flagship Real Life Insurance policy contain?

Christopher Hall, AdvDipFP, Authorised Representative, AFSL 526688, reviewed the flagship PDS (H9097_12/24) against the same 26 fields applied to every product on Arrow Equities' comparison spine.

Death and terminal illness. Entry ages 18–74; minimum $100,000; maximum age-banded from $2,000,000 (ages 18–44) down to $200,000 (ages 70–74), with cover above $1,000,000 requiring annual income of at least $50,000 (p.13). Guaranteed renewable each year while premiums are paid (p.16). An Advance Funeral Benefit of 20% of the benefit, capped at $20,000 (pp.8, 15).

Premiums. The premium structure is stepped — the PDS states that the premium "will increase based on your age each year on the Policy Anniversary plus any automatic Benefit Amount increases" (p.26). The sum insured also increases automatically by 5% each Policy Anniversary unless declined, continuing to age 75 (p.30), so the premium rises for age and for the larger sum insured in the same year. Rates can be repriced for a whole group of policies on 90 days' written notice (p.27). No level-premium alternative appears in the document (searched pp.9, 26–27).

Special Terms. Underwriting is conducted by telephone. Outcomes may include a premium loading, an exclusion, a reduced Benefit Amount, an Accident Only Period, or a maximum Policy Term (p.12). Where a maximum Policy Term is applied, the policy runs only to the 20th Policy Anniversary or the 85th birthday (pp.15, 42), only Accidental Death is covered for the first 12 months (p.16), the benefit is capped at $200,000 regardless of age (p.13), the Serious Illness and TPD options cannot be added (pp.17, 20), and cover cannot later be increased (p.31).

Serious Illness option. Four insured events: Cancer excluding specified early-stage cancers; Heart Attack with evidence of severe permanent heart muscle damage; Heart Bypass Surgery; and Stroke resulting in specified permanent impairment (pp.8, 17). Entry 18–59, ending at the Policy Anniversary after the 65th birthday (pp.17, 19); capped at 50% of the life cover (p.18); a 14-day survival period and a three-month qualifying period apply (pp.17–18); and payment reduces the life and TPD benefits dollar-for-dollar (p.18).

TPD option. The definition is any-occupation: unable to work in any employed capacity for at least six consecutive months and, in the insurer's reasonable opinion, unable ever to follow any occupation for which the person is reasonably qualified by education, training or experience (p.44). Entry 18–59, ending at 65 (pp.20, 22); maximum $1,000,000; payment reduces the life and Serious Illness benefits (p.21); motor sport is excluded (p.21).

How do those same clauses read in an adviser-distributed policy?

Four adviser-distributed products were extracted using the identical 26 fields, so the comparison is like-for-like rather than selective. This is a comparison of what the documents state, not a ranking, and it covers only the products named.

Two of those four come from the same company. Zurich Australia Limited (ABN 92 000 010 195, AFSL 232510) issues Zurich Wealth Protection and, trading as OnePath Life, issues OneCare — two product ranges from one Australian life insurer, not two insurers.

The table records what each document states. It is not a ranking and it is not a price comparison: the four adviser-distributed products are separately underwritten and separately priced, several of the benefits listed are options carrying their own premium rather than features of every policy issued, and the trauma and TPD covers described are separate products rather than components of the death cover they sit alongside. What a given policyholder actually holds is set by their own Policy Schedule.

Four scenarios show what those rows mean at the point a claim is made.

Loss of a hand in an accident. Under Zurich Wealth Protection the accidental injury benefit pays the lower of 25% of the death benefit and $500,000, and it sits inside the death cover itself (1 Nov 2025, p.11); under MetLife Protect the Specified Events Option pays 50% of the base life cover, capped at $250,000, where that option has been taken (16 Nov 2025, pp.38–39). TAL Accelerated Protection and OnePath OneCare reach the same event by a different route — each pays 25% of the TPD amount insured, capped at $500,000, but only where TPD cover has been taken and, in both documents, only where the cover is held outside superannuation (TAL 12 Dec 2025, p.37; OneCare 30 Mar 2026, p.32). The Real Life Insurance PDS contains no specific-injury schedule, so no benefit is payable on that event alone; loss of limbs appears only as one trigger within the any-occupation TPD definition, and only where the TPD option was taken and the person is unable ever to work again in any suited occupation (H9097_12/24, p.44).

An early-stage cancer diagnosis. MetLife Protect pays up to 10% of the trauma cover, capped at $50,000 (p.56); Zurich Wealth Protection pays a 20% partial trauma benefit capped at $100,000 (p.17); OnePath OneCare pays 10% capped at $20,000 on its Comprehensive and Premier trauma cover (p.43); and TAL Accelerated Protection pays an Advancement Benefit of 10% to 25%, capped between $50,000 and $100,000, on its Premier trauma cover only (p.46). Under the Real Life Insurance Serious Illness option, specified early-stage cancers are expressly excluded from the cancer definition, so the policy would not pay a benefit on that diagnosis (pp.37–38).

A second, unrelated critical illness some years after a first claim. All four adviser-distributed documents offer an option to reinstate the trauma cover after a claim — MetLife's Trauma Cover Reinstatement Option (p.58), Zurich's trauma reinstatement option (p.25), TAL's Critical Illness Reinstatement Option, one of five reinstatement and buy-back options in that document (pp.45, 48), and OneCare's Trauma Cover Reinstatement, one of seven (pp.63–67). No reinstatement or buy-back option appears in the Real Life Insurance PDS; a Serious Illness or TPD payment permanently reduces the remaining life cover by the amount paid (pp.18, 21).

Diagnosis with a life expectancy of 18 months. Whether that meets the terminal illness test depends on the document, and a simple count of months understates the difference. Of the seven documents reviewed, four apply a 24-month test and would pay at 18 months — Real Life Insurance (H9097_12/24, p.43), Real Life Cover for SMSF (H7994_07/23, p.24), MetLife Protect (p.34) and Zurich Wealth Protection (p.101). Two apply a 12-month test and would not — Real Term Life Cover (H7995_07/23, p.23), which would additionally not pay a terminal illness benefit at all within the first 12 months of the policy (p.10), and TAL Accelerated Protection (p.93). The seventh, OnePath OneCare, defines terminal illness at 12 months (p.109) but carries a standard Extended Terminal Medical Condition feature that pays the full benefit at 24 months where two practitioners, one an appropriate specialist, so certify (p.26) — so it would pay at 18 months, and counting it as a 12-month document would misstate what it does.

Three of the adviser-distributed documents also state something none of the three Real PDSs state: how a claim is assessed against the Life Insurance Code of Practice, and whether policy improvements flow through to existing policyholders. The wording is not the same in each. OneCare assesses a trauma claim on the first $2 million of Comprehensive and Premier cover against the better of the PDS definition and the current Code medical definition (30 Mar 2026, p.2). Zurich Wealth Protection assesses the first $2 million of trauma against both the PDS definition and the corresponding Code definition and pays if either is met, with updated Code definitions applied automatically (1 Nov 2025, p.3). TAL adopts the Code, and states its effect differently: the Code governs where a PDS definition specifies an obsolete method of diagnosis or treatment, rather than operating as a general either-definition test (12 Dec 2025, pp.3, 96). Each of those three documents also states that improvements to policy terms are incorporated into existing policies automatically (Zurich p.8; TAL p.76; OneCare p.13). No alternative-definition assessment and no benefit-upgrade clause appears in the MetLife Protect PDS or in any of the three Real PDSs reviewed.

Why does a directly purchased policy often cost more, not less?

The mechanism is underwriting, not discounting.

Where a policy is issued with limited or no medical underwriting, the insurer must price for an unfavourable assumption about the applicant's health, and the policyholder carries that cost for the life of the policy. Full underwriting works across the whole spectrum of medical history rather than the obvious conditions alone.

In Christopher Hall's experience across 500+ policy reviews, clients arriving from a direct or comparison-site purchase have frequently held the policy ten to fifteen years, and three defects recur together: the sum insured is low relative to the family's actual need; nothing has been structured to capture any available tax deduction; and the premium is elevated because the health questions were never properly asked. This is an observed pattern across reviews, not a prediction about any individual policy.

Christopher Hall compares the buying context to shopping in an airport terminal: the buyer is pressed for time, wants a quick solution, and generally accepts that a fast purchase made under time pressure is not the same transaction as a considered one. That trade-off is unremarkable for a souvenir. Where the cover is intended to carry a family's livelihood, the same speed is worth revisiting — either by getting the cover right at the outset, or, where it was arranged quickly, by having it compared soon afterwards against the market.

The billing frequency compounds it. Premiums charged weekly or fortnightly present as a small instalment and are easy not to notice; the same premium annualised is a materially larger figure, and it is the annualised figure that a stepped structure escalates each year. In Christopher Hall's experience across 500+ policy reviews, the gap between what a directly purchased policy costs over a year and what the same person could have been placed at for the same cover amount is frequently in the order of a family holiday. Because that gap is only ever charged in weekly or fortnightly instalments, it is never presented to the policyholder as an annual figure, and so it is rarely the thing that prompts a comparison.

Which insurer is the most competitively priced?

There is no stable answer, which is why Arrow Equities re-runs the comparison rather than assuming it.

Asked which insurer is best, Christopher Hall's answer is that it depends on age, occupation, risk category, level of cover and state — and that the answer changes month to month, which is why the comparison is re-run rather than assumed.

Arrow Equities publishes a monthly premium ranking built from standardised occupation profiles — an electrician, a nurse, a carer, a sales assistant and a teacher — each quoted to a locked specification and re-quoted every month. Those results roll into the monthly insurer ranking, which is scoped to Arrow Equities' panel and ranks on price only, not on product quality.

Christopher Hall attributes the movement to the pricing matrix each insurer's actuaries use: rates are set cell by cell across age, gender, occupation class, cover type and definition, so adjacent cells can move in opposite directions rather than following a smooth curve. Where an insurer is already heavily exposed in one age-and-occupation cell and thin in another, it can price those cells to slow or attract new business.

Arrow Equities advises across a panel of leading Australian insurers including Acenda, ClearView and NEOS, among others, with recommendations based on client needs rather than insurer commissions or sales targets.

What should a Real policyholder check first?

Six checks, in order. The first is the one most often skipped.

1. Is there a premium projection, and what does it show at 10 and 20 years? No forward premium projection appears in any of the three Real Product Disclosure Statements reviewed; the flagship PDS discloses only that the premium is recalculated each year on age (H9097_12/24, p.26) and that the sum insured rises 5% annually unless declined (p.30). Where a projection was supplied with the original quotation, it can be checked against an adviser-run projection on the same cover; where none was supplied, one can be requested from the insurer, and an adviser can model the same cover across the same period for comparison. A projection is standard in an adviser-prepared quotation because a stepped premium is not a flat cost — it is a curve, and the shape of that curve over 10 and 20 years is the single largest financial variable in the policy.

2. Which product is it? The Policy Schedule names the PDS. The three products reviewed here differ on terminal illness, waiting period, expiry and maximum cover.

3. Is there a maximum Policy Term or an Accident Only Period on the schedule? Both are disclosed outcomes of the Special Terms clause and both materially change what the policy does (H9097_12/24, p.12).

4. When does the death benefit end? Annually renewable, or the 20th anniversary or age 85?

5. What is the sum insured now, after indexation? A 5% automatic increase compounds, and so does the premium attached to it.

6. Has the cover been compared since it was issued? A policy bought on a competitive quote in one year is not necessarily on a competitive quote several years later — the same mechanism as the loyalty tax, seen from the purchase side rather than the renewal side.

A structured insurance premium review works through all six against the policy documents rather than a quote screen. Where a quotation or projection is already held, it can be sent through ahead of the review and read alongside the corresponding PDS.

Book a quick review with an adviser

Book a quick review with an adviser now. The review identifies which Real product is actually held, reads the Policy Schedule and PDS against each other for special conditions, and re-runs the comparison against the current month's pricing — rather than working from an online summary.

Find out if you're eligible →

Frequently Asked Questions

Is Real life insurance any good?

That question cannot be answered about the brand as a whole, because Real Insurance issues several separate life policies with materially different terms. The Real Life Insurance PDS (H9097_12/24) provides annually renewable cover to $2,000,000 with a 24-month terminal illness definition; the Real Term Life Cover PDS (H7995_07/23) caps cover at $100,000, pays nothing for non-accidental death in the first 12 months, and expires at the 20th anniversary or age 85. Suitability depends on which product is held and on the policyholder's circumstances.

Who underwrites Real life insurance?

Hannover Life Re of Australasia Ltd, ABN 37 062 395 484, AFSL 530811. Real Insurance is the trading name of the distributor, Greenstone Financial Services Pty Ltd, ABN 53 128 692 884, AFSL 343079.

Does Real life insurance have a waiting period?

It depends on the product. Under Real Term Life Cover (H7995_07/23, pp.7, 10, 12) only Accidental Death is covered for the first 12 months after the Acceptance Date, so a death from illness in that period would not be paid. Under Real Life Insurance (H9097_12/24, p.14) death from any cause is covered from the start, subject to a 13-month intentional self-inflicted act exclusion (p.16).

Does Real life insurance cover loss of a limb?

No specific-injury schedule appears in the Real Life Insurance PDS (H9097_12/24, pp.8–25) or the Real Term Life Cover PDS (H7995_07/23, pp.7–17), so no benefit is payable for that event on its own. Loss of limbs appears only as one trigger within the any-occupation TPD definition, where the TPD option has been taken (p.44). The four adviser-distributed documents reviewed reach the event three different ways: Zurich Wealth Protection pays 25% of the death benefit capped at $500,000 for loss of use of one hand, foot or eye as a benefit built into death cover (1 Nov 2025, p.11); MetLife Protect pays 50% capped at $250,000 under the Specified Events Option where that option has been taken (16 Nov 2025, pp.38–39); and TAL Accelerated Protection and OnePath OneCare each pay 25% of the TPD amount insured capped at $500,000, but only where TPD cover has been taken and, in both documents, only where the cover is held outside superannuation (12 Dec 2025, p.37; 30 Mar 2026, p.32).

Does Real life insurance cover early-stage cancer?

No. Specified early-stage cancers are expressly excluded from the cancer definition in the Real Life Insurance Serious Illness option (H9097_12/24, pp.37–38), so the policy would not pay a benefit on that diagnosis. Each of the four adviser-distributed documents reviewed pays something on an early-stage diagnosis: MetLife Protect up to 10% of the trauma cover capped at $50,000 (16 Nov 2025, p.56); Zurich Wealth Protection a 20% partial trauma benefit capped at $100,000 (1 Nov 2025, p.17); OnePath OneCare 10% capped at $20,000 on Comprehensive and Premier (30 Mar 2026, p.43); and TAL Accelerated Protection an Advancement Benefit of 10% to 25%, capped between $50,000 and $100,000, on Premier only (12 Dec 2025, p.46).

How many conditions does Real's serious illness cover include?

Four: Cancer excluding specified early-stage cancers, Heart Attack with evidence of severe permanent heart muscle damage, Heart Bypass Surgery, and Stroke resulting in specified permanent impairment (H9097_12/24, pp.8, 17). The four adviser-distributed documents reviewed list larger and tiered sets on their trauma covers — 45 conditions in MetLife Protect (pp.56–57), 43 plus 13 partial-payment conditions in Zurich Wealth Protection (p.20), 38 on TAL's Standard and 40 on its Premier critical illness cover (12 Dec 2025, p.44), and, in OnePath OneCare, 47 on Comprehensive, 45 full plus 19 partial on Premier and 34 full plus 39 tiered-partial on Severity (30 Mar 2026, pp.39, 42–45). Those covers are separate products with their own premiums, not a like-for-like substitute for the Real Serious Illness option.

Can a Real serious illness or TPD benefit be reinstated after a claim?

No reinstatement or buy-back option appears in the Real Life Insurance PDS; a Serious Illness or TPD payment permanently reduces the remaining life cover by the amount paid (H9097_12/24, pp.18, 21). All four adviser-distributed documents reviewed carry options of that kind: MetLife Protect a Trauma Cover Reinstatement Option and a Life Cover Buy Back Option (16 Nov 2025, p.58); Zurich Wealth Protection six reinstatement and buy-back options (1 Nov 2025, pp.23–27); TAL Accelerated Protection five (12 Dec 2025, pp.37–38, 45, 48); and OnePath OneCare seven (30 Mar 2026, pp.63–67). Each is an option or an included benefit under those documents rather than a feature of every policy issued.

What does Real life insurance not cover?

Each PDS sets its own exclusions. Common to the products reviewed is an exclusion for death or terminal illness by intentional self-inflicted act within 13 months of acceptance, increase or reinstatement (H9097_12/24, p.16). The Serious Illness option covers four defined conditions only (p.17), and specified early-stage cancers, prostate cancers below the stated thresholds, and non-melanoma skin cancers are excluded from the cancer definition (pp.37–38).

Does Real life insurance come with a premium projection?

No forward premium projection appears in any of the three Real Product Disclosure Statements reviewed for this article. The flagship PDS discloses the mechanism — the premium is recalculated each Policy Anniversary on the policyholder's age, and the sum insured rises 5% automatically unless declined (H9097_12/24, pp.26, 30) — but not the resulting figures over time. A projection may have been supplied with the original quotation; where it was, it can be compared against an adviser-run projection on the same cover, and where it was not, one can be requested from the insurer.

How much do Real life insurance premiums increase each year?

The PDS does not state a percentage. It states the mechanism: the premium is recalculated each Policy Anniversary using the rate for the policyholder's new age, the sum insured increases 5% automatically unless declined, and rates can additionally be changed for a whole group of policies on 90 days' written notice (H9097_12/24, pp.26, 27, 30). The compounding of those three together is what a 10- and 20-year projection makes visible, and it is the reason a stepped premium is assessed as a curve rather than as a current monthly figure.

Why do Real life insurance premiums go up every year?

The premium structure is stepped, so it is recalculated each Policy Anniversary using the rate for the policyholder's new age, and the sum insured also rises by 5% automatically unless the increase is declined (H9097_12/24, pp.26, 30). Rates can additionally be changed for a whole group of policies on 90 days' written notice (p.27). No level-premium alternative appears in the document.

Can Real life insurance cover be increased later?

The PDS permits an application to increase cover unless a maximum Policy Term applies to the policy (H9097_12/24, p.31). Under Real Term Life Cover, cover cannot be increased and a partner cannot be added at any time after the Acceptance Date (H7995_07/23, p.16). No feature permitting an increase without health assessment appears in either document. All four adviser-distributed documents reviewed carry one: MetLife Protect through its Life Events Increases Feature (16 Nov 2025, p.35), Zurich Wealth Protection through future insurability across 12 listed life events (1 Nov 2025, p.27), TAL Accelerated Protection through Guaranteed Future Insurability across 10 personal and 3 business events subject to a $1,000,000 lifetime cap (12 Dec 2025, pp.51–52), and OnePath OneCare through Future Insurability across 10 personal, 2 business and 1 policy event, also subject to a $1,000,000 lifetime cap (30 Mar 2026, pp.56–60).

Is a life insurance claim assessed against the Life Insurance Code of Practice?

It depends on the document, and only some say. Three of the seven Product Disclosure Statements reviewed for this article address it. OnePath OneCare states that a trauma claim on the first $2 million of Comprehensive and Premier cover is assessed against the better of the PDS definition and the current Code medical definition (30 Mar 2026, p.2). Zurich Wealth Protection states that the first $2 million of trauma cover is assessed against both the PDS definition and the corresponding Code definition and qualifies if either is met, with updated Code definitions applied automatically (1 Nov 2025, p.3). TAL Accelerated Protection adopts the Code, with the stated effect that it governs where a PDS definition specifies an obsolete method of diagnosis or treatment, rather than as a general either-definition test (12 Dec 2025, pp.3, 96). Nothing of that kind appears in the MetLife Protect PDS or in any of the three Real Product Disclosure Statements. What differs between these documents is whether, and in what terms, the PDS records the Code's effect on a claim — not a statement about how any insurer assesses claims in practice.

What is the difference between Real Life Insurance and Real Term Life Cover?

They are separate policies under separate PDSs. Real Life Insurance covers $100,000–$2,000,000, is annually renewable, pays death from any cause from the start, and defines terminal illness as 24 months. Real Term Life Cover covers $10,000–$100,000, expires at the 20th anniversary or age 85, pays only Accidental Death for the first 12 months, and defines terminal illness as 12 months.

Does Real life insurance pay a terminal illness benefit?

Yes, under all three products reviewed, but on different tests: 24 months' life expectancy under Real Life Insurance (H9097_12/24, p.43); 12 months, and only after the policy has been held 12 months, under Real Term Life Cover (H7995_07/23, pp.10, 23); and 24 months certified by two Medical Practitioners plus the SIS Act terminal medical condition under the SMSF product (H7994_07/23, p.24). Across the seven documents reviewed for this article, four apply a 24-month test, two apply 12 months, and one — OnePath OneCare — defines terminal illness at 12 months (30 Mar 2026, p.109) but reaches 24 months through a standard Extended Terminal Medical Condition feature (p.26). A diagnosis carrying an 18-month life expectancy would therefore meet the test in five of the seven; under Real Term Life Cover and under TAL Accelerated Protection (12 Dec 2025, p.93) it would not.

Is it cheaper to buy life insurance directly online?

Not by reason of the channel. In Christopher Hall's experience across 500+ policy reviews, the insurers listed on comparison sites are largely the same insurers Arrow Equities places business with, and industry discounts have been substantially removed in recent years. Where a policy is issued with little or no medical underwriting, the insurer prices for an unfavourable assumption about the applicant's health, and that cost is carried for the life of the policy.

Which life insurer is cheapest in Australia?

The answer changes month to month and depends on age, occupation, risk category, level of cover and state of residence. Arrow Equities publishes a monthly panel-scoped premium ranking built from locked occupation profiles for exactly this reason; it ranks on price only, not on product quality.

How can a policyholder find out which Real product they hold?

The Policy Schedule issued at acceptance names the product and the PDS version it was issued under, and shows any special conditions applied. Where the schedule cannot be located, the insurer can reissue it, and an adviser can read it alongside the corresponding PDS.

About the author

Christopher Hall, AdvDipFP, is the principal financial adviser at Arrow Equities and an Authorised Representative under AFSL 526688. He has completed more than 500 life insurance policy reviews for Australian families, with a specialisation in life risk insurance.

Bibliography

All product references are to the Product Disclosure Statement versions listed above as at August 2026. Product terms change; the current Product Disclosure Statement should be confirmed before any decision is made.

Disclaimer

Educational Disclaimer: This content is for educational purposes only and does not constitute financial advice. Past performance is no guarantee of future results.

The information, opinions and other materials appearing on the Web Site are of a general nature only and shall not be construed as advice. Arrow Equities, AFSL 526688, ABN 87 645 284 680. This general information is educational only and not financial advice, recommendation, forecast or solicitation. Rose Bay Equities accepts no responsibility for the accuracy or completeness of the information, opinions or other materials provided on or accessible through the Web Site. The Web Site has not been prepared with reference to your individual financial or personal circumstances. You should not rely on any advice in this Web Site without first seeking appropriate professional, financial and legal advice. Further, where Rose Bay Equities makes third party material available or accessible through the Web Site you acknowledge that Rose Bay Equities is a distributor and not a publisher of that content and that its editorial control is limited to the selection of those materials to make available. We accept no liability for any loss or damages arising from use.